328 participants
To Explore the Optimal Therapeutic Window for Imatinib in the Adjuvant Treatment of Intermediate and High-risk Gastrointestinal Stromal Tumors
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-05-29
- Start Date:
- 2015-01-01
- Completion:
- 2025-12-31
Conditions
- Gastrointestinal Stromal Tumors (GISTs)
No Results Yet